Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Open Access
- 22 January 2009
- journal article
- Published by American Society of Hematology
- Vol. 113 (4), 936-944
- https://doi.org/10.1182/blood-2008-06-163675
Abstract
The protease thrombin is required for normal hemostasis and pathologic thrombogenesis. Since the mechanism of coagulation factor XI (FXI)–dependent thrombus growth remains unclear, we investigated the contribution of FXI to thrombus formation in a primate thrombosis model. Pretreatment of baboons with a novel anti–human FXI monoclonal antibody (aXIMab; 2 mg/kg) inhibited plasma FXI by at least 99% for 10 days, and suppressed thrombin-antithrombin (TAT) complex and β-thromboglobulin (βTG) formation measured immediately downstream from thrombi forming within collagen-coated vascular grafts. FXI inhibition with aXIMab limited platelet and fibrin deposition in 4-mm diameter grafts without an apparent increase in D-dimer release from thrombi, and prevented the occlusion of 2-mm diameter grafts without affecting template bleeding times. In comparison, pretreatment with aspirin (32 mg/kg) prolonged bleeding times but failed to prevent graft occlusion, supporting the concept that FXI blockade may offer therapeutic advantages over other antithrombotic agents in terms of bleeding complications. In whole blood, aXIMab prevented fibrin formation in a collagen-coated flow chamber, independent of factor XII and factor VII. These data suggest that endogenous FXI contributes to arterial thrombus propagation through a striking amplification of thrombin generation at the thrombus luminal surface.Keywords
This publication has 51 references indexed in Scilit:
- Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Feedback activation of factor XI by thrombin does not occur in plasmaProceedings of the National Academy of Sciences of the United States of America, 2007
- Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primatesBlood, 2007
- Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XIIBlood, 2006
- von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectivelyJournal of Thrombosis and Haemostasis, 2006
- Identification of a Factor IX Binding Site on the Third Apple Domain of Activated Factor XIPublished by Elsevier BV ,1996
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier BV ,1996
- Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.JCI Insight, 1993
- Fibrin clots obtained from plasma containing heparin show a higher sensitivity to t-PA-induced lysisBlood Coagulation & Fibrinolysis, 1992
- Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.JCI Insight, 1988